| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/28/2005 | CN1220872C Method and device for recording images of grains from cereals to detect cracking |
| 09/28/2005 | CN1220521C Hapten-carrier conjugates for treating and preventing nicotine addiction |
| 09/28/2005 | CN1220510C Chinese patent medicine with the functions of replenishing qi and blood and nourishing the heart to calm the mind, its preparation method and quality control method |
| 09/28/2005 | CN1220509C Chinese patent medicine for curing cardiovascular disease, its preparation method and quality control method |
| 09/27/2005 | US6950767 Quality monitoring system for building structure, quality monitoring method for building structure and semiconductor integrated circuit device |
| 09/27/2005 | US6950762 Device for examining liquids |
| 09/27/2005 | US6950757 Screening methods for identifying ligands |
| 09/27/2005 | US6950756 recombining cells into a virtual array image that provides only feature cells which are relevant and appropriate to the subject analysis |
| 09/27/2005 | US6950752 Methods for removing artifact from biological profiles |
| 09/27/2005 | US6949936 Method and apparatus for the debris particulate characterization in lubricants |
| 09/27/2005 | US6949659 cyanine, xanthene, porphyrin or coumarin dyes, used for marking probes, including nucleic acids and proteins |
| 09/27/2005 | US6949638 Photolithographic method and system for efficient mask usage in manufacturing DNA arrays |
| 09/27/2005 | US6949632 Fluorogenic substrate for use as diagnostic tools in the analysis of enzymatic activity |
| 09/27/2005 | US6949628 Detection of infections in humans; obtain sample, incubate with antibody, detect signal, presence of signal indicates infection |
| 09/27/2005 | US6949626 Bacillus thuringiensis cryET33 and cryET34 compositions and uses therefor |
| 09/27/2005 | US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders |
| 09/27/2005 | US6949524 Medicine and clinical chemistry |
| 09/27/2005 | US6949506 Relaxin-like factor and methods and uses thereof |
| 09/27/2005 | US6949384 Using spectrophotometry to monitor degradation of hemoglobin blood substitutes; hemolysis |
| 09/27/2005 | US6949382 for providing biochemical analysis of antioxidant function in human lymphocytes |
| 09/27/2005 | US6949380 culturing a proliferating epidermal basal cell population, exposing the cell(s) to fetuin, noggin, chordin, gremlin, follistatin, growing the cell(s) in the presence of an antisense oligonucleotide antagonist of bone morphogenetic protein (BMP) |
| 09/27/2005 | US6949376 Nucleic acid amplification reaction station for disposable test devices |
| 09/27/2005 | US6949357 Reagents and methods useful for detecting diseases of the urinary tract |
| 09/27/2005 | US6949354 Detection of nervous system modulators; obtain preferential nervous system tissue in vitro, culture, incubate with modulator, monitor and evaluate adjustment in cell activity |
| 09/27/2005 | US6949353 capable of acting as an guanylyltransferase and methyltransferase consisting of a polypeptide from the N-terminus of flavivirus genus RNA-dependent RNA polymerase |
| 09/27/2005 | US6949351 adding adenosine diphosphate (ADP) to a sample which allows the conversion of ADP to adenosine triphosphate (ATP) by cellular adenylate kinase, detecting ATP in the sample and relating amount of ATP detected to the presence of adenylate kinase |
| 09/27/2005 | US6949350 cells are incubated concurrently with a marker whose interaction with phosphatidylserine can be detected and with at least one drug, and the interaction between the marker and phosphatidylserine is detected in a time-resolved manner |
| 09/27/2005 | US6949349 incubating a phagemid clone displaying the peptide, with the IGF in the presence of the IGFBP at high and low concentrations of the phagemid clone, measuring the degree to which binding of the phagemid clone to the IGFBP is inhibited by IGF |
| 09/27/2005 | US6949348 such as Creutzfeldt-Jacob disease in cattle; assaying antibodies present in the mammal which bind antigenic peptide which is mimetic of mammalian myelin peptide; kits |
| 09/27/2005 | US6949347 Binding compounds derivatized with releasable molecular tags specifically bind to selected membrane-associated analytes; diagnosis/medical; released upon activation of cleavage moieties, or sensitizers; diagnosis/medical/; drugs |
| 09/27/2005 | US6949346 Using antibody released by hybridomas cells |
| 09/27/2005 | US6949345 Identification and cloning of a mycobacterial antigen corresponding to a heparin-binding haemagglutinin |
| 09/27/2005 | US6949344 Hair analysis method |
| 09/27/2005 | US6949337 Contacting human vpr interacting protein with a test compound and comparing the affinity of the vpr in the presence and absence of it |
| 09/27/2005 | US6949246 Monoclonal/polyclonal antibodies for serodetection and treatment of mycobacterium infections |
| 09/27/2005 | US6949244 produced by hybridoma cell line ATCC No. HB 12020; elicits an immune response against (human milk fat globule) HMFG in non-human primates |
| 09/27/2005 | US6949221 Method of making a test strip for determining analyte concentration over a broad range of sample volumes |
| 09/27/2005 | US6949206 Organic species that facilitate charge transfer to or from nanostructures |
| 09/27/2005 | US6948423 Apparatus for producing confectionery |
| 09/27/2005 | US6948353 Quick response structure of gas sensor |
| 09/27/2005 | US6948352 Self-calibrating carbon monoxide detector and method |
| 09/27/2005 | CA2428206C Methods for the treatment of cellular proliferative disorders |
| 09/27/2005 | CA2392292C Determination of kappa number in chemical pulps by raman spectrometry |
| 09/27/2005 | CA2280272C Capacitive oil deterioration and contamination sensor |
| 09/27/2005 | CA2245680C Method of detection of influenza virus and compounds for use therein |
| 09/27/2005 | CA2149120C Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 09/27/2005 | CA2137654C Method for improving measurement precision in evanescent wave optical biosensor assays |
| 09/27/2005 | CA2113351C Reversible flow chromatographic binding assay |
| 09/27/2005 | CA2108104C Fibrin sealant compositions and methods for utilizing same |
| 09/26/2005 | CA2502060A1 Microfluidic analytical system with position electrodes |
| 09/26/2005 | CA2502024A1 Constant contact wheel for close interval survey devices |
| 09/24/2005 | CA2502403A1 System for testing paving materials |
| 09/22/2005 | WO2005088319A2 Test element analysis system with contact surfaces coated with hard material |
| 09/22/2005 | WO2005088315A1 Recombinant human tsh in the diagnosis of central hypothyroidism |
| 09/22/2005 | WO2005088314A1 Hybrid nanoparticles including an ln2o3 core and having bioligands, and method for preparing same |
| 09/22/2005 | WO2005088313A1 Method to predict risk of bph progression |
| 09/22/2005 | WO2005088312A1 Autoantibody detection for cancer diagnostics |
| 09/22/2005 | WO2005088311A1 Method for detecting neoplastic disorders in a solubilized body sample |
| 09/22/2005 | WO2005088310A2 High throughput glycan microarrays |
| 09/22/2005 | WO2005088309A1 Method of measuring affinity substance |
| 09/22/2005 | WO2005088308A2 Fluorescent signal emitting live cell biosensor molecules and dyes for detection and quantification of protein activities |
| 09/22/2005 | WO2005088307A1 Immunoassays for everolimus |
| 09/22/2005 | WO2005088306A2 Biologically-active dna-binding sites and related methods |
| 09/22/2005 | WO2005088305A1 Method of stabilizing oxidizable color-assuming reagent |
| 09/22/2005 | WO2005088304A1 Methods and compositions for screening involving endothelial cells under shearing conditions |
| 09/22/2005 | WO2005088303A2 Identification and characterization of proteins using new database search modes |
| 09/22/2005 | WO2005088302A1 Methods and systems for identification of macromolecules |
| 09/22/2005 | WO2005088301A1 Method for detection of malaria and other parasite infections |
| 09/22/2005 | WO2005088300A1 Assay chip |
| 09/22/2005 | WO2005088299A1 Method of assaying dermal permeability of transdermal drug mediated by dermal transporter |
| 09/22/2005 | WO2005088289A1 Detection of no with a semi-conducting compound and a sensor and device to detect no |
| 09/22/2005 | WO2005088287A1 Method and apparatus for the detection of microorganisms |
| 09/22/2005 | WO2005088286A2 Universal explosive material detector |
| 09/22/2005 | WO2005088285A1 Micro thermoelectric type gas sensor |
| 09/22/2005 | WO2005088085A1 Method and device for the real-time measurement of the consumption of oil from an engine oil separation system, using radioactive tracers |
| 09/22/2005 | WO2005087954A2 Roles of foxc2, pdgfr, vegfr3 in lymphatic vessel development |
| 09/22/2005 | WO2005087950A1 Method of detecting nucleic acid using amplification on an array |
| 09/22/2005 | WO2005087948A2 Cancer treatment and assays for determining resistance to platinum-based chemotherapeutic agent |
| 09/22/2005 | WO2005087946A1 Method of measuring glycoprotein |
| 09/22/2005 | WO2005087943A1 Temporal or spatial characterization of biosynthetic events in living organisms by isotopic fingerprinting under conditions of imposed isotopic gradients |
| 09/22/2005 | WO2005087925A1 Recombinant gene, disease animal model and method of evaluating test substance |
| 09/22/2005 | WO2005087924A1 Dna chip and method of extracting disease-associated genes |
| 09/22/2005 | WO2005087919A1 Crystal structure of 3',5'-cyclic nucleotide phosphodiesterase (pde10a) and uses thereof |
| 09/22/2005 | WO2005087812A1 Multivalent antibody materials and methods for vegf/pdgf family of growth factors |
| 09/22/2005 | WO2005087807A1 Vr1 receptors and uses thereof |
| 09/22/2005 | WO2005087796A1 Novel phosphorylated sequences of phosphatase cdc25b, antibodies directed against said sequences and use thereof |
| 09/22/2005 | WO2005087784A1 Electrochemically active ligand for sequence-specific detection of double-stranded nucleic acid molecule |
| 09/22/2005 | WO2005087603A1 Container with lid |
| 09/22/2005 | WO2005087376A1 Analyte collection and detection devices |
| 09/22/2005 | WO2005087357A1 System and method for mixing water and non-aqueous materials using measured water concentration to control addition of ingredients |
| 09/22/2005 | WO2005087271A1 Compositions comprising cells and magnetic materials for targeted delivery |
| 09/22/2005 | WO2005087249A1 Protease inhibitor and preventives or remedies for diseases |
| 09/22/2005 | WO2005087089A1 Method and apparatus for detecting endometriosis |
| 09/22/2005 | WO2005086965A2 A process and apparatus for improving and controlling the curing of natural and synthetic moldable compounds |
| 09/22/2005 | WO2005086954A2 Conductance of improperly folded proteins through the secretory pathway and related methods for treating disease |
| 09/22/2005 | WO2005086891A2 Classification of breast cancer patients using a combination of clinical criteria and informative genesets |
| 09/22/2005 | WO2005086875A2 A humanized anti-cea t84.66 antibody and uses thereof |
| 09/22/2005 | WO2005086830A2 Raman-enhancing, and non-linear optically active nano-sized optical labels and uses thereof |
| 09/22/2005 | WO2005086827A2 Methods of assessing the need for and the effectiveness of therapy with antioxidants |
| 09/22/2005 | WO2005086798A2 Improved interleukin-2 muteins |